Ideaya Biosciences is only slightly up on the day, shares traded 0.71% higher on the day.
It looks like Ideaya Biosciences isn't currently at a very decisive point in regards to support/resistance levels. Ideaya Biosciences hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. IDYA might find some support at the 21 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on IDEAYA Biosciences right now, so not much useful information here. The current Analysts Sentiment Score is 8.30. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. JPMorgan Chase & Co. provided a price target boost of 11.76% to $57.00 from $51.00 on 2024-02-23. On 2024-02-22 there was confirmation of the previous rating by Capital One Financial which was Overweight. Royal Bank of Canada gave a boost to their price target and moved to $53.00 from $43.00 on 2024-02-21. On 2024-01-25 The Goldman Sachs Group increased their price target by 47.22% to $53.00. Guggenheim dropped their price target by -8.33% to $44.00 on 2023-11-08. On 2023-11-08 there was confirmation of the previous rating by Wedbush which was Outperform and provided a price target of $43.00. Oppenheimer gave a boost to their price target and moved to $35.00 from $30.00 on 2023-08-11. SVB Securities initiated a rating of Outperform on 2023-08-08 and added a price target of $33.00. On 2023-08-08 SVB Leerink started covering IDEAYA Biosciences with a rating of Outperform and they set their price target at $33.00.Leerink Partnrs reiterated a rating of Outperform on 2023-08-08.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| IDYA | 8.30 | 7.92 | 0 | 9.12 | -0.45 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| IDYA | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| IDYA | 11.95 | %13.7 | 11.7 | -10.164 | 6700000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| IDYA |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | 0.88 | 1.94 | 2.11 | -11.12 | 1.02 | 30.63 | 34.11 | 69 | 74.38 | 103.30 | 59.38 | 116.84 | -22833.86 | 0 | 0 | 11.2371 |
| RLAY | Relay Therapeutics, Inc. | 0.81 | 2.37 | -2.86 | -21.23 | -30.04 | -29.84 | -41.29 | 44 | -44.92 | -34.26 | -48.04 | -38225.23 | -295.06 | 0 | 0 | 11.3947 |
| CLDX | Celldex Therapeutics, Inc | 0.8 | 3.05 | 15.92 | -3.40 | -34.62 | -23.63 | -5.76 | 54 | -23.82 | -28.70 | -26.70 | -21974.39 | -1634.25 | 0 | 0 | 11.5064 |
| KYMR | Kymera Therapeutics, Inc. | 0.74 | 3.38 | 6.06 | -8.35 | -6.99 | 34.15 | 125.46 | 62 | 83.89 | 52.65 | 70.80 | -421.97 | -12923.42 | 0 | 0 | 13.6584 |
| XNCR | Xencor, Inc. | 0.73 | 3.78 | 7.85 | 15.95 | 43.00 | 6.88 | 33.46 | 83 | 16.10 | 7.18 | 7.98 | -4734.49 | -11116.17 | 0 | 0 | 15.4823 |
| PRTA | Prothena Corporation plc | 0.72 | 1.11 | 8.07 | -17.00 | -34.44 | -26.82 | -56.01 | 52 | -58.27 | -62.55 | -120.81 | -707.56 | -1197.68 | 0 | 0 | 11.1209 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
